Cerebrovascular disorders in children

Current Neurology and Neuroscience Reports

Volumn 4, Issue 2, 2004, Pages 129-138

  Lynch, John Kylan ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; FOLIC ACID; HEPARIN; HYDROXYUREA; LOW MOLECULAR WEIGHT HEPARIN; VITAMIN B GROUP; WARFARIN;

ANAMNESIS; ARTERY DISSECTION; BACTERIAL INFECTION; BLEEDING DISORDER; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN VEIN; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGENITAL HEART DISEASE; CRANIECTOMY; DECOMPRESSION SURGERY; DIFFUSION WEIGHTED IMAGING; DOPPLER ECHOGRAPHY; ECHOCARDIOGRAPHY; EXCHANGE BLOOD TRANSFUSION; HEALTH SURVEY; HEART DISEASE; HEMATOLOGIC DISEASE; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; MAGNETIC RESONANCE ANGIOGRAPHY; MEDICAL ASSESSMENT; METABOLIC DISORDER; MOYAMOYA DISEASE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PHLEBOGRAPHY; PRIMARY PREVENTION; RECURRENCE RISK; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SICKLE CELL ANEMIA; TREATMENT PLANNING; VASCULAR DISEASE; VEIN THROMBOSIS; VIRUS INFECTION; ADOLESCENT; INFANT; NEWBORN; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; INTRACRANIAL HEMORRHAGES; INTRACRANIAL THROMBOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 1842539353     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-004-0027-3     Document Type: Review

References (78)

1. Schoenberg BS, Mellinger JF, Schoenberg DG: Cerebrovascular disease in infants and children: a study of incidence, clinical features, and survival. Neurology 1978, 28:763-768.
2. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurology 2004, In press.
3. Broderick J, Talbot GT, Prenger E, et al.: Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol 1993, 8:250-255.
4. Giroud M, Lemesle M, Gouyon JB, et al.: Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 1995, 48:1343-1348.
5. Earley CJ, Kittner SJ, Feeser BR, et al.: Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 1998, 51:169-176.
6. DeVeber G, and the Canadian Ischemic Stroke Study Group: Canadian Pediatric Stroke Registry: analysis of children with arterial ischemic stroke [abstract]. Ann Neurol 2000, 48:526.
7. Fullerton HJ, Wu YW, Zhao S, Johnston SC: Risk of stroke in children: ethnic and gender disparities. Neurology 2003, 61:189-194.
8. Lynch JK: The hospitalization of childhood stroke in the United States, 1979-2000 [abstract]. Stroke 2003, 34:287.
9. Lanthier S, Carmant L, David M, et al.: Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000, 54:371-378.
10. Ganesan V, Prengler M, McShane MA, et al.: Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 2003, 53:167-173.
11. Roach ES, Riela AR: Pediatric Cerebrovascular Disorders, edn 2. Armonk, NY: Futura Publishing Company, 1995.
12. Strater R, Becker S, von Eckardstein A, et al.: Prospective assessment of risk factors for recurrent stroke during childhood - a 5-year follow-up study. Lancet 2002, 360:1540-1545.
13. Kirkham FJ, Prengler M, Hewes DK, Ganesan V: Risk factors for arterial ischemic stroke in children. J Child Neurol 2000, 15:299-307.
14. Lanska MJ, Lanska DJ, Horwitz SJ, Aram DM: Presentation, clinical course, and outcome of childhood stroke. Pediatr Neurol 1991, 7:333-341.
15. Kumar K: Neurological complications of congenital heart disease. Indian J Pediatr 2000, 67:S15-S19.
16. Strauss A, Toth B, Schwab B, et al.: Prenatal diagnosis of congenital heart disease and neonatal outcome - a six years experience. Eur J Med Res 2001, 6:66-70.
17. Mahle WT, Tavani F, Zimmerman RA, et al.: An MRI study of neurological injury before and after congenital heart surgery. Circulation 2002, 106:I109-I114.
18. Miller G, Mamourian AC, Tesman JR, et al.: Long-term MRI changes in brain after pediatric open heart surgery. J Child Neurol 1994, 9:390-397.
19. Pegelow CH, Macklin EA, Moser FG, et al.: Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood 2002, 99:3014-3018.
20. Scothorn DJ, Price C, Schwartz D, et al.: Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr 2002, 140:348-354.
21. Powars D, Wilson B, Imbus C, et al.: The natural history of stroke in sickle cell disease. Am J Med 1978, 65:461-471.
22. Steen RG, Emudianughe T, Hankins GM, et al.: Brain imaging findings in pediatric patients with sickle cell disease. Radiology 2003, 228:216-225.
23. Adams RJ: Stroke prevention and treatment in sickle cell disease. Arch Neurol 2001, 58:565-568.
24. Akar N, Akar E, Deda G, et al.: Factor V1691 G-A, prothrombin 20210 G-A, and methylenetetrahydrofolate reductase 677 C-T variants in Turkish children with cerebral infarct. J Child Neurol 1999, 14:749-751.
25. Kenet G, Sadetzki S, Murad H, et al.: Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 2000, 31:1283-1288.
26. Nowak-Gottl U, Strater R, Heinecke A, et al.: Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999, 94:3678-3682.
27. Hagstrom JN, Walter J, Bluebond-Langner R, et al.: Prevalence of the factor V leiden mutation in children and neonates with thromboembolic disease. J Pediatr 1998, 133:777-781.
28. Bonduel M, Sciuccati G, Hepner M, et al.: Factor V Leiden and prothrombin gene G20210A mutation in children with cerebral thromboembolism. Am J Hematol 2003, 73:81-86.
29. McColl MD, Chalmers EA, Thomas A, et al.: Factor V Leiden, prothrombin 20210G-->A and the MTHFR C677T mutations in childhood stroke. Thromb Haemost 1999, 81:690-694.
30. Zenz W, Bodo Z, Plotho J, et al.: Factor V Leiden and prothrombin gene G 20210 A variant in children with ischemic stroke. Thromb Haemost 1998, 80:763-766.
31. Strater R, Vielhaber H, Kassenbohmer R, et al.: Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey. Eur J Pediatr 1999, 158(suppl 3):S122-S125.
32. Fullerton HJ, Johnston SC, Smith WS: Arterial dissection and stroke in children. Neurology 2001, 57:1155-1160.
33. Lindsberg PJ, Grau AJ: Inflammation and infections as risk factors for ischemic stroke. Stroke 2003, 34:2518-2532.
34. Snyder RD, Stovring J, Cushing AH, et al.: Cerebral infarction in childhood bacterial meningitis. J Neurol Neurosurg Psychiatry 1981, 44:581-585.
35. Sebire G, Meyer L, Chabrier S: Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann Neurol 1999, 45:679-680.
36. Ichiyama T, Houdou S, Kisa T, et al.: Varicella with delayed hemiplegia. Pediatr Neurol 1990, 6:279-281.
37. Askalan R, Laughlin S, Mayank S, et al.: Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 2001, 32:1257-1262.
38. Kirkham FJ: Stroke in childhood. Arch Dis Child 1999, 81:85-89.
39. Riela AR, Roach ES: Etiology of stroke in children. J Child Neurol 1993, 8:201-220.
40. Zimmerman RA, Haselgrove JC, Wang Z, et al.: Advances in pediatric neuroimaging. Brain Dev 1998, 20:275-289.
41. Koelfen W, Wentz U, Freund M, Schultze C: Magnetic resonance angiography in 140 neuropediatric patients. Pediatr Neurol 1995, 12:31-38.
42. Adams RJ, McKie VC, Carl EM, et al.: Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler. Ann Neurol 1997, 42:699-704.
43. Inamasu J, Ichikizaki K, Matsumoto S, et al.: Mild hypothermia for hemispheric cerebral infarction after evacuation of an acute subdural hematoma in an infant. Child Nerv Syst 2002, 18:175-178.
44. Thirumalai SS, Shubin RA: Successful treatment for stroke in a child using recombinant tissue plasminogen activator. J Child Neurol 2000, 15:558.
45. Noser EA, Felberg RA, Alexandrov AV: Thrombolytic therapy in an adolescent ischemic stroke. J Child Neurol 2001, 16:286-288.
46. Golomb MR, Rafay M, Armstrong D, et al.: Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl. J Child Neurol 2003, 18:420-423.
47. Younkin DP: Diagnosis and treatment of ischemic pediatric stroke. Curr Neurol Neurosci Rep 2002, 2:18-24.
48. Lee MC, Frank JI, Kahana M, et al.: Decompressive hemicraniectomy in a 6-year-old male after unilateral hemispheric stroke. Case report and review. Pediatr Neurosurg 2003, 38:181-185.
49. Andrew M, DeVeber G: Pediatric Thromboembolism and Stroke Protocols, edn 2. Hamilton, Ontario: BC Decker; 1999.
50. Adams RJ, McKie VC, Hsu L, et al.: Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N Engl J Med 1998, 339:5-11.
51. Clancy RR, McGaurn SA, Goin JE, et al.: Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics 2001, 108:61-70.
52. Houkin K, Kuroda S, Nakayama N: Cerebral revascularization for moyamoya disease in children. Neurosurg Clin North Am 2001, 12:575-84.
53. Wang WC, Kovnar EH, Tonkin IL, et al.: High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr 1991, 118:377-382.
54. Sumoza A, de Bisotti R, Sumoza D, Fairbanks V: Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA). Am J Hematol 2002, 71:161-165.
55. Cardo E, Monros E, Colome C, et al.: Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J Child Neurol 2000, 15:295-298.
56. Ganesan V, Ng V, Chong WK, et al.: Lesion volume, lesion location, and outcome after middle cerebral artery territory stroke. Arch Dis Child 1999, 81:295-300.
57. Yang JS, Park YD, Hartlage PL: Seizures associated with stroke in childhood. Pediatr Neurol 1995, 12:136-138.
58. Max JE, Mathews K, Lansing AE, et al.: Psychiatric disorders after childhood stroke. J Am Acad Child Adolesc Psychiatry 2002, 41:555-562.
59. Wang LH, Young C, Lin HC, et al.: Strokes in children: a medical center-based study. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1998, 39:242-246.
60. Arias E, Anderson RN, Kung HC, et al.: Deaths: final data for 2001. Natl Vital Stat Rep 2003, 52:1-115.
61. Fullerton HJ, Chetkovich DM, Wu YW et al.: Deaths from stroke in US children, 1979 to 1998. Neurology 2002, 59:34-39.
62. DeVeber G, Monagle P, Chan A, et al.: Prothrombotic disorders in infants and children with cerebral thromboembolism. Arch Neurol 1998, 55:1539-1543.
63. Chabrier S, Husson B, Lasjaunias P, et al.: Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol 2000, 15:290-294.
64. Kirkham F, DeVeber G, Chan AK, et al.: Recurrent stroke: the role of prothrombotic disorders [abstract]. Ann Neurol 2003, 54:S110.
65. Strater R, Kurnik K, Heller C, et al.: Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study. Stroke 2001, 32:2554-2558.
66. Meyer-Heim AD, Boltshauser E: Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev 2003, 25:416-421.
67. Livingston JH, Brown JK: Intracerebral haemorrhage after the neonatal period. Arch Dis Child 1986, 61:538-544.
68. Fults D, Kelly DL: Natural history of arteriovenous malformations of the brain: a clinical study. Neurosurgery 1984, 15:658-662.
69. Al Jarallah A, Al Rifai MT, Riela AR, Roach ES: Nontramnatic brain hemorrhage in children: etiology and presentation. J Child Neurol 2000, 15:284-289.
70. Broderick JP, Adams HP Jr, Barsan W, et al.: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999, 30:905-915.
71. Shroff M, deVeber G: Sinovenous thrombosis in children. Neuroimaging Clin North Am 2003, 13:115-138.
72. DeVeber G, Andrew M: Cerebral sinovenous thrombosis in children. N Engl J Med 2001, 345:417-423.
73. Heller C, Heinecke A, Junket R, et al.: Cerebral venous thrombosis in children: a multifactorial origin. Circulation 2003, 108:1362-1367.
74. Huisman TA, Holzmann D, Martin E, Willi UV: Cerebral venous thrombosis in childhood. Eur Radiol 2001, 11:1760-1765.
75. Lovblad KO, Bassetti C, Schneider J, et al.: Diffusion-weighted MR in cerebral venous thrombosis. Cerebrovasc Dis 2001, 11:169-176.
76. Selim M, Fink J, Linfante I, et al.: Diagnosis of cerebral venous thrombosis with echo-planar T2*-weighted magnetic resonance imaging. Arch Neurol 2002, 59:1021-1026.
77. deVeber G, Chan A, Monagle P, et al.: Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Neurology 1998, 51:1622-1628.
78. Canhao P, Falcao F, Ferro JM: Thrombolytics for cerebral sinus thrombosis: a systematic review. Cerebrovasc Dis 2003, 15:159-166.